VistaGen Therapeutics Inc (NASDAQ:VTGN)

Delayed Data
As of Sep 18
 -0.03 / -2.50%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for VistaGen Therapeutics Inc have a median target of 2.35, with a high estimate of 4.00 and a low estimate of 0.70. The median estimate represents a +100.85% increase from the last price of 1.17.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in VistaGen Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.00%
Growthannually 55.19%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.